Homoarginine in the renal and cardiovascular systems

Amino Acids

Volumn 47, Issue 9, 2015, Pages 1703-1713

  Pilz, Stefan ^a,b   Meinitzer, Andreas ^a   Gaksch, Martin ^a   Grübler, Martin ^a   Verheyen, Nicolas ^a   Drechsler, Christiane ^c   Hartaigh, Bríain Ó ^d   Lang, Florian ^e   Alesutan, Ioana ^e   Voelkl, Jakob ^e   März, Winfried ^a,f   Tomaschitz, Andreas ^a,g,h  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^e UNIVERSITY OF TÜBINGEN   (Germany)

^f SYNLAB ACADEMY   (Germany)

^g Specialist Clinic for Rehabilitation Bad Aussee   (Austria)

^h CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

AGAT; Cardiovascular; Heart failure; Homoarginine; Mortality; Nitric oxide; Stroke

Indexed keywords

ARGININE; GLYCINE AMIDINOTRANSFERASE; HOMOARGININE; NITRIC OXIDE; AMIDINOTRANSFERASE; BIOLOGICAL MARKER; GLYCINE; GUANIDINOACETIC ACID;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; AMINO ACID SYNTHESIS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CHRONIC DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL DECISION MAKING; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG TARGETING; ENERGY METABOLISM; ENZYME ACTIVITY; HEART FAILURE; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MORTALITY; NEUROLOGIC DISEASE; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SUPPLEMENTATION; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; METABOLISM;

AMIDINOTRANSFERASES; ANIMALS; BIOMARKERS; CEREBROVASCULAR DISORDERS; ENERGY METABOLISM; GLYCINE; HEART FAILURE; HOMOARGININE; HUMANS; KIDNEY DISEASES; NITRIC OXIDE;

EID: 84940461365     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-015-1993-2     Document Type: Article

References (77)

1. Al Banachaabouchi M, Marescau B, Van Marck E, D'hooge R, Deyn PP (2001) Long-term effect of partial nephrectomy on biochemical parameters, kidney histology, and guanidine compound levels in mice. Metabolism 50:1418-1425
2. Atzler D, Rosenberg M, Anderssohn M, Choe CU, Lutz M, Zugck C, Böger RH, Frey N, Schwedhelm E (2013) Homoarginine-an independent marker of mortality in heart failure. Int J Cardiol 168:4907-4909
3. Atzler D, Gore MO, Ayers CR, Choe CU, Böger RH, de Lemos JA, McGuire DK, Schwedhelm E (2014a) Homoarginine and cardiovascular outcome in the population based Dallas Heart Study. Arterioscler Thromb Vasc Biol 34:2501-2507
4. Atzler D, Schwedhelm E, Nauck M, Ittermann T, Boger RH, Friedrich N (2014b) Serum reference intervals of homoarginine, ADMA, and SDMA in the Study of Health in Pomerania. Clin Chem Lab Med 52:1835-1842
5. Atzler D, Schwedhelm E, Choe CU (2015) l-homoarginine and cardiovascular disease. Curr Opin Clin Nutr Metab Care 18:83-88
6. Bell EA (1962) The isolation of L-homoarginine from seeds of Lathyrus cicero. Biochem J 85:91-93
7. Bernstein HG, Jäger K, Dobrowolny H, Steiner J, Keilhoff G, Bogerts B, Laube G (2015) Possible sources and functions of L-homoarginine in the brain: review of the literature and own findings. Amino Acids. 2015 Mar 20 (Epub ahead of print)
8. Blachier F, Mourtada A, Sener A, Malaisse WJ (1989) Stimulus-secretion coupling of arginine-induced insulin release. uptake of metabolized and nonmetabolized cationic amino acids by pancreatic islets. Endocrinology 124:134-141
9. Chambers JC, Zhang W, Lord GM, van der Harst P, Lawlor DA, Sehmi JS et al (2010) Genetic loci influencing kidney function and chronic kidney disease. Nat Genet 42:373-375
10. Chen PY, Sanders PW (1993) Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats. Hypertension 22:812-818
11. Choe CU, Nabuurs C, Stockebrand MC, Neu A, Nunes P, Morellini F, Sauter K, Schillemeit S, Hermans-Borgmeyer I, Marescau B, Heerschap A, Isbrandt D (2013a) l-arginine:glycine amidinotransferase deficiency protects from metabolic syndrome. Hum Mol Genet 22:110-123
12. Choe CU, Atzler D, Wild PS, Carter AM, Böger RH, Ojeda F, Simova O, Stockebrand M, Lackner K, Nabuurs C, Marescau B, Streichert T, Müller C, Lüneburg N, De Deyn PP, Benndorf RA, Baldus S, Gerloff C, Blankenberg S, Heerschap A, Grant PJ, Magnus T, Zeller T, Isbrandt D, Schwedhelm E (2013b) Homoarginine levels are regulated by l-arginine:glycine amidinotransferase and affect stroke outcome: results from human and murine studies. Circulation 128:1451-1461
13. Cullen ME, Yuen AH, Felkin LE, Smolenski RT, Hall JL, Grindle S, Miller LW, Birks EJ, Yacoub MH, Barton PJ (2006) Myocardial expression of the arginine:glycine amidinotransferase gene is elevated in heart failure and normalized after recovery: potential implications for local creatine synthesis. Circulation 114(1 Suppl):I16-I20
14. Davids M, Ndika JD, Salomons GS, Blom HJ, Teerlink T (2012) Promiscuous activity of arginine:glycine amidinotransferase is responsible for the synthesis of the novel cardiovascular risk factor homoarginine. FEBS Lett 586:3653-3657
15. Drechsler C, Meinitzer A, Pilz S, Krane V, Tomaschitz A, Ritz E, März W, Wanner C (2011a) Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients. Eur J Heart Fail 13:852-859
16. Drechsler C, Verduijn M, Pilz S, Krediet RT, Dekker FW, Wanner C, Ketteler M, Boeschoten EW, Brandenburg V, NECOSAD Study Group (2011b) Bone alkaline phosphatase and mortality in dialysis patients. Clin J Am Soc Nephrol 6:1752-1759
17. Drechsler C, Kollerits B, Meinitzer A, März W, Ritz E, König P, Neyer U, Pilz S, Wanner C, Kronenberg F, MMKD Study Group (2013) Homoarginine and progression of chronic kidney disease: results from the mild to moderate kidney disease study. Plos One 8:e63560
18. Drechsler C, Pihlstrøm H, Meinitzer A, Pilz S, Tomaschitz A, Abedini S, Fellstrom B, Jardine AG, Wanner C, März W, Holdaas H (2015) homoarginine and clinical outcomes in renal transplant recipients: results from the assessment of lescol in renal transplantation study. Transplantation (Epub ahead of print)
19. Edvardson S, Korman SH, Livne A, Shaag A, Saada A, Nalbandian R, Allouche-Arnon H, Gomori JM, Katz-Brull R (2010) l-arginine:glycine amidinotransferase (AGAT) deficiency: clinical presentation and response to treatment in two patients with a novel mutation. Mol Genet Metab 101:228-232
20. Hafner F, Kieninger A, Meinitzer A, Gary T, Froehlich H, Haas E, Hackl G, Eller P, Brodmann M, Seinost G (2014) Endothelial dysfunction and brachial intima-media thickness: long term cardiovascular risk with claudication related to peripheral arterial disease: a prospective analysis. PLoS ONE 9:e93357. doi: 10.1371/journal.pone.0093357
21. Hall JL, Birks EJ, Grindle S, Cullen ME, Barton PJ, Rider JE, Lee S, Harwalker S, Mariash A, Adhikari N, Charles NJ, Felkin LE, Polster S, George RS, Miller LW, Yacoub MH (2007) Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy. Eur Heart J 28:613-627
22. Henningsson R, Lundquist I (1998) Arginine induced insulin release is decreased and glucagon increased in parallel with islet NO production. Am J Physiol 275:E500-E506
23. Hinterseher I, Erdman R, Elmore JR, Stahl E, Pahl MC, Derr K, Golden A, Lillvis JH, Cindric MC, Jackson K, Bowen WD, Schworer CM, Chernousov MA, Franklin DP, Gray JL, Garvin RP, Gatalica Z, Carey DJ, Tromp G, Kuivaniemi H (2013) Novel pathways in the pathobiology of human abdominal aortic aneurysms. Pathobiology 80:1-10
24. Hoberman HD, Sims EA, Engstrom WW (1948) The effect of methyltestosterone on the rate of synthesis of creatine. J Biol Chem 173:111-116
25. Jaźwińska-Kozuba A, Martens-Lobenhoffer J, Kruszelnicka O, Rycaj J, Chyrchel B, Surdacki A, Bode-Böger SM (2013) Opposite associations of plasma homoarginine and ornithine with arginine in healthy children and adolescents. Int J Mol Sci 14:21819-21832
26. Kakoki M, Kim HS, Arendshorst WJ, Mattson DL (2004) l-Arginine uptake affects nitric oxide production and blood flow in the renal medulla. Am J Physiol Regul Integr Comp Physiol 287:R1478-R1485
27. Kayacelebi AA, Nguyen TH, Neil C, Horowitz JD, Jordan J, Tsikas D (2014) Homoarginine and 3-nitrotyrosine in patients with takotsubo cardiomyopathy. Int J Cardiol 173:546-547
28. Kayacelebi AA, Willers J, Pham VV, Hahn A, Schneider JY, Rothmann S, Frölich JC, Tsikas D (2015) Plasma homoarginine, arginine, asymmetric dimethylarginine and total homocysteine interrelationships in rheumatoid arthritis, coronary artery disease and peripheral artery occlusion disease. Amino Acids 2015 Jan 25 (Epub ahead of print)
29. Khalil AA, Tsikas D, Akolekar R, Jordan J, Nicolaides KH (2013) Asymmetric dimethylarginine, arginine and homoarginine at 11-13 weeks gestation and preeclampsia: a case-control study. J Hum Hypertens 27:38-43
30. Kielstein J, Flieser D (2007) The past, presence and future of ADMA in nephrology. Nephrol Ther 3:47-54
31. Kleber ME, Seppälä I, Pilz S, Hoffmann MM, Tomaschitz A, Oksala N, Raitoharju E, Lyytikäinen LP, Mäkelä KM, Laaksonen R, Kähönen M, Raitakari OT, Huang J, Kienreich K, Fahrleitner-Pammer A, Drechsler C, Krane V, Boehm BO, Koenig W, Wanner C, Lehtimäki T, März W, Meinitzer A (2013) Genome-wide association study identifies 3 genomic loci significantly associated with serum levels of homoarginine: the AtheroRemo Consortium. Circ Cardiovasc Genet 6:505-513
32. Köttgen A, Glazer NL, Dehghan A, Hwang SJ, Katz R, Li M et al (2009) Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet 41:712-717
33. Krebs A, Doerfer J, Grünert SC, Wöhrl J, Stier B, Schmidt-Trucksäss A, Lichte K, Winkler K, Grulich-Henn J, Holder M, Schwab KO (2015) Decreased levels of homoarginine and asymmetric dimethylarginine in children with type 1 diabetes: associations with cardiovascular risk factors but no effect by atorvastin. J Pediatr Endocrinol Metab 28:147-152
34. Levillain O, Marescau B, de Deyn PP (1995) Guanidino compound metabolism in rats subjected to 20% to 90% nephrectomy. Kidney Int 47:464-472
35. Lygate CA, Bohl S, ten Hove M, Faller KM, Ostrowski PJ, Zervou S, Medway DJ, Aksentijevic D, Sebag-Montefiore L, Wallis J, Clarke K, Watkins H, Schneider JE, Neubauer S (2012) Moderate elevation of intracellular creatine by targeting the creatine transporter protects mice from acute myocardial infarction. Cardiovasc Res 96:466-475
36. Lygate CA, Aksentijevic D, Dawson D, ten Hove M, Phillips D, de Bono JP, Medway DJ, Sebag-Montefiore L, Hunyor I, Channon KM, Clarke K, Zervou S, Watkins H, Balaban RS, Neubauer S (2013) Living without creatine: unchanged exercise capacity and response to chronic myocardial infarction in creatine-deficient mice. Circ Res 112:945-955
37. Magnusson P, Farley P (2002) Differences in sialic acid residues among bone alkaline phosphatase isoforms: a physical, biochemical, and immunological characterization. Calcif Tissue Int 71:508-518
38. Marescau B, Deshmukh DR, Kockx M, Possemiers I, Qureshi IA, Wiechert P, De Deyn PP (1992) Guanidino compounds in serum, urine, liver, kidney, and brain of man and some ureotelic animals. Metabolism 41:526-532
39. Marescau B, Nagels G, Possemiers I, De Broe ME, Becaus I, Billiouw JM, Lornoy W, De Deyn PP (1997) Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency. Metabolism 46:1024-1031
40. März W, Meinitzer A, Drechsler C, Pilz S, Krane V, Kleber ME, Fischer J, Winkelmann BR, Böhm BO, Ritz E, Wanner C (2010) Homoarginine, cardiovascular risk, and mortality. Circulation 122:967-975
41. May M, Kayacelebi AA, Batkai S, Jordan J, Tsikas D, Engeli S (2015) Plasma and tissue homoarginine concentrations in healthy and obese humans. Amino Acids (Epub ahead of print)
42. McClure WC, Rabon RE, Ogawa H, Tseng BS (2007) Upregulation of the creatine synthetic pathway in skeletal muscles of mature mdx mice. Neuromuscul Disord 17:639-650
43. McGuire DM, Tormanen CD, Segal IS, Van Pilsum JF (1980) The effect of growth hormone and thyroxine on the amount of l-arginine:glycine amidinotransferase in kidneys of hypophysectomized rats. Purification and some properties of rat kidney transamidinase. J Biol Chem 255:1152-1159
44. Meinitzer A, Drechsler C, Tomaschitz A, Pilz S, Krane V, Wanner C, März W (2011a) Homoarginine: a new cardiovascular risk marker in hemodialysis patients. LaboratoriumsMedizin 35:153-159
45. Meinitzer A, Kielstein JT, Pilz S, Drechsler C, Ritz E, Boehm BO, Winkelmann BR, März W (2011b) Symmetrical and asymmetrical dimethylarginine as predictors for mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study. Clin Chem 57:112-121
46. Moali C, Boucher JL, Sari MA, Stuehr DJ, Mansuy D (1998) Substrate specificity of NO synthases: detailed comparison of l-arginine, homo-l-arginine, their N omega-hydroxy derivatives, and N omega-hydroxynor-l-arginine. Biochemistry 37:10453-10460
47. Ndika JD, Johnston K, Barkovich JA, Wirt MD, O'Neill P, Betsalel OT, Jakobs C, Salomons GS (2012) Developmental progress and creatine restoration upon long-term creatine supplementation of a patient with arginine:glycine amidinotransferase deficiency. Mol Genet Metab 106:48-54
48. Phillips D, Ten Hove M, Schneider JE, Wu CO, Sebag-Montefiore L, Aponte AM, Lygate CA, Wallis J, Clarke K, Watkins H, Balaban RS, Neubauer S (2010) Mice over-expressing the myocardial creatine transporter develop progressive heart failure and show decreased glycolytic capacity. J Mol Cell Cardiol 48:582-590
49. Pilz S, Tomaschitz A, Meinitzer A, Drechsler C, Ritz E, Krane V, Wanner C, Bohm BO, März W (2011a) Low serum homoarginine is a novel risk factor for fatal strokes in patients undergoing coronary angiography. Stroke 42:1132-1134
50. Pilz S, Meinitzer A, Tomaschitz A, Drechsler C, Ritz E, Krane V, Wanner C, Boehm BO, März W (2011b) Low homoarginine concentration is a novel risk factor for heart disease. Heart 97:1222-1227
51. Pilz S, Meinitzer A, Tomaschitz A, Kienreich K, Fahrleitner-Pammer A, Drechsler C, Boehm BO, März W (2012) Homoarginine deficiency is associated with increased bone turnover. Osteoporos Int 23:2731-2732
52. Pilz S, Meinitzer A, Tomaschitz A, Kienreich K, Dobnig H, Schwarz M, Wagner D, Drechsler C, Piswanger-Sölkner C, März W, Fahrleitner-Pammer A (2013) Associations of homoarginine with bone metabolism and density, muscle strength and mortality: cross-sectional and prospective data from 506 female nursing home patients. Osteoporos Int 24:377-381
53. Pilz S, Teerlink T, Scheffer PG, Meinitzer A, Rutters F, Tomaschitz A, Drechsler C, Kienreich K, Nijpels G, Stehouwer CD, März W, Dekker JM (2014a) Homoarginine and mortality in an older population: the Hoorn study. Eur J Clin Invest 44:200-208
54. Pilz S, Edelmann F, Meinitzer A, Gelbrich G, Döner U, Düngen HD, Tomaschitz A, Kienreich K, Gaksch M, Duvinage A, Stahrenberg R, Kunde J, Schmidt A, März W, Wachter R, Pieske B (2014b) Associations of methylarginines and homoarginine with diastolic dysfunction and cardiovascular risk factors in patients with preserved left ventricular ejection fraction. J Card Fail 20:923-930
55. Radomski MW, Palmer RM, Moncada S (1990) An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci U S A 87:5193-5197
56. Rao SL, Ramachandran LK, Adiga PR (1963) The isolation and characterization of l-homoarginine from seeds of Lathyrus sativus. Biochemistry 2:298-300
57. Ravani P, Maas R, Malberti F, Pecchini P, Mieth M, Quinn R, Tripepi G, Mallamaci F, Zoccali C (2013) Homoarginine and mortality in pre-dialysis chronic kidney disease (CKD) patients. PLoS ONE 8:e72694
58. Rodionov RN, Murry DJ, Vaulman SF, Stevens JW, Lentz SR (2010) Human alanine-glyoxylate aminotransferase 2 lowers asymmetric dimethylarginine and protects from inhibition of nitric oxide production. J Biol Chem 285:5385-5391
59. Ryan WL, Well IC (1964) Homocitrulline and homoarginine synthesis from lysine. Science 144:1122-1127
60. Schwegler F, Stock W (1975) Effects of arginine homologous and other guanidino compounds on the ATP level and glucose oxidation in isolated fat cells. Hoppe Seylers Z Physiol Chem 356:839-844
61. Shimomura A, Matsui I, Hamano T, Ishimoto T, Katou Y, Takehana K, Inoue K, Kusunoki Y, Mori D, Nakano C, Obi Y, Fujii N, Takabatake Y, Nakano T, Tsubakihara Y, Isaka Y, Rakugi H (2014) Dietary l-lysine prevents arterial calcification in adenine-induced uremic rats. J Am Soc Nephrol 25:1954-1965
62. Singh SS, Rao SL (2013) Lessons from neurolathyrism: a disease of the past & the future of Lathyrus sativus (Khesari dal). Indian J Med Res 138:32-37
63. Sobczak A, Prokopowicz A, Radek M, Szula M, Zaciera M, Kurek J, Goniewicz ML (2014) Tobacco smoking decreases plasma concentration of the emerging cardiovascular risk marker, L-homoarginine. Circ J 78:1254-1258
64. Steib H (1926) Über d, l-α-Methylarginin. Hoppe Seylers Z Physiol Chem 155:279-291
65. Stevens CM, Bush JA (1950) New synthesis of α-amino-ε-guanidino-n-caprionic acid (homoarginine) and its possible conversion in vivo into lysine. J Biol Chem 183:139-147
66. Summar ML, Gainer JV, Pretorius M, Malave H, Harris S, Hall LD, Weisberg A, Vaughan DE, Christman BW, Brown NJ (2010) Relationship between carbamoyl-phosphate synthetase genotype and systemic vascular function. Hypertension 43:186-191
67. Tofuku Y, Muramoto H, Kuroda M, Takeda R (1985) Impaired metabolism of guanidinoacetic acid in uremia. Nephron 41:174-178
68. Tomaschitz A, Meinitzer A, Pilz S, Rus-Machan J, Genser B, Drechsler C, Grammer T, Krane V, Ritz E, Kleber ME, Pieske B, Kraigher-Krainer E, Fahrleitner-Pammer A, Wanner C, Boehm BO, März W (2014) Homoarginine, kidney function and cardiovascular mortality risk. Nephrol Dial Transplant 29:663-667
69. Tomaschitz A, Verheyen N, Gaksch M, Meinitzer A, Pieske B, Kraigher-Krainer E, Colantonio C, März W, Schmidt A, Belyavskiy E, Rus-Machan J, van Ballegooijen AJ, Stiegler C, Amrein K, Ritz E, Fahrleitner-Pammer A, Pilz S (2015) Homoarginine in Patients With Primary Hyperparathyroidism. Am J Med Sci 349:306-311
70. Tsikas D, Kayacelebi AA (2014) Do Homoarginine and asymmetric dimethylarginine act antagonistically in the cardiovascular system? Circ J 78:2094-2095
71. Tsikas D, Böger RH, Sandmann J, Bode-Böger SM, Fröhlich JC (2000) Endogenous nitric oxide synthase inhibitors are responsible for the l-arginine paradox. FEBS Lett 478:1-3
72. Valtonen P, Laitinen T, Lyyra-Laitinen T, Raitakari OT, Juonala M, Viikari JS, Heiskanen N, Vanninen E, Punnonen K, Heinonen S (2008) Serum l-homoarginine concentration is elevated during normal pregnancy and is related to flow-mediated vasodilatation. Circ J 72:1879-1884
73. van der Zwan LP, Davids M, Scheffer PG, Dekker JM, Stehouwer CD, Teerlink T (2013) L-Homoarginine and l-arginine are antagonistically related to blood pressure in an elderly population: the Hoorn study. J Hypertens 31:1114-1123
74. Vogl L, Pohlhammer J, Meinitzer A, Rantner B, Stadler M, Peric S, Hammerer-Lercher A, Klein-Weigel P, Fraedrich G, Kronenberg F, Kollerits B (2015) Serum concentrations of l-arginine and l-homoarginine in male patients with intermittent claudication: a cross-sectional and prospective investigation in the CAVASIC Study. Atherosclerosis 239:607-614
75. Wu F, Cholewa B, Mattson DL (2000) Characterization of l-arginine transporters in rat renal inner medullary collecting duct. Am J Physiol Regul Integr Comp Physiol 278:R1506-R1512
76. Wu G, Bazer FW, Davis TA, Kim SW, Li P, Marc Rhoads J, Carey Satterfield M, Smith SB, Spencer TE, Yin Y (2009) Arginine metabolism and nutrition in growth, health and disease. Amino Acids 37:153-168
77. Zhu Y, Evans MI (2001) Estrogen modulates the expression of l-arginine:glycine amidinotransferase in chick liver. Mol Cell Biochem 221:139-145